In this case, Nadal-Serrano et al. developed models of acquired resistance using the PDX118 cell line obtained from a mouse that was implanted with a cutaneous metastasis of a patient with HER2+ breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.